Toward a Gene Therapy for Dominant Disease: Validation of an RNA Interference-Based Mutation-Independent Approach
Open Access
- 1 September 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (3), 555-561
- https://doi.org/10.1016/j.ymthe.2005.03.028
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Systemic siRNA-Mediated Gene SilencingAnnals of Surgery, 2004
- Argonaute Journeys into the Heart of RISCScience, 2004
- The RNAi revolutionNature, 2004
- RNAi of COL1A1 in mesenchymal progenitor cellsEuropean Journal of Human Genetics, 2004
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004
- Coupling of RNAi-Mediated Target Downregulation with Gene ReplacementAntisense and Nucleic Acid Drug Development, 2003
- siRNA-mediated gene silencing in vitro and in vivoNature Biotechnology, 2002
- Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfectaHuman Molecular Genetics, 2002
- RNA interference in adult miceNature, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002